News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
839,715 Results
Type
Article (75818)
Company Profile (726)
Press Release (763151)
Multimedia
Podcasts (192)
Webinars (29)
Section
Business (227262)
Career Advice (3740)
Deals (39354)
Drug Delivery (151)
Drug Development (89521)
Employer Resources (205)
FDA (18114)
Job Trends (17191)
News (387911)
Policy (38893)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (3017)
Academic (1)
Accelerated approval (36)
Adcomms (36)
Allergies (154)
Alliances (56012)
ALS (183)
Alzheimer's disease (1811)
Antibody-drug conjugate (ADC) (360)
Approvals (18301)
Artificial intelligence (604)
Autoimmune disease (182)
Automation (40)
Bankruptcy (403)
Best Places to Work (12633)
BIOSECURE Act (23)
Biosimilars (207)
Biotechnology (447)
Bladder cancer (164)
Brain cancer (66)
Breast cancer (679)
Cancer (5141)
Cardiovascular disease (454)
Career advice (3206)
Career pathing (42)
CAR-T (313)
CDC (60)
Celiac Disease (2)
Cell therapy (834)
Cervical cancer (38)
Clinical research (75742)
Collaboration (1884)
Company closure (4)
Compensation (1202)
Complete response letters (77)
COVID-19 (2997)
CRISPR (103)
C-suite (924)
Cystic fibrosis (155)
Data (6440)
Decentralized trials (2)
Denatured (68)
Depression (157)
Diabetes (543)
Diagnostics (7260)
Digital health (52)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (289)
Drug pricing (226)
Drug shortages (36)
Duchenne muscular dystrophy (248)
Earnings (97160)
Editorial (67)
Employer branding (25)
Employer resources (174)
Events (134050)
Executive appointments (1054)
FDA (21378)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (11)
Frontotemporal dementia (24)
Funding (1584)
Gene editing (222)
Generative AI (58)
Gene therapy (680)
GLP-1 (1144)
Government (5410)
Grass and pollen (8)
Guidances (387)
Healthcare (20942)
HIV (67)
Huntington's disease (51)
IgA nephropathy (88)
Immunology and inflammation (304)
Immuno-oncology (66)
Indications (113)
Infectious disease (3299)
Inflammatory bowel disease (212)
Inflation Reduction Act (17)
Influenza (126)
Intellectual property (261)
Interviews (730)
IPO (17870)
IRA (61)
Job creations (4958)
Job search strategy (2597)
JPM (71)
Kidney cancer (17)
Labor market (97)
Layoffs (659)
Leadership (41)
Legal (9940)
Liver cancer (99)
Longevity (15)
Lung cancer (695)
Lymphoma (388)
Machine learning (44)
Management (66)
Manufacturing (872)
MASH (179)
Medical device (15040)
Medtech (15098)
Mergers & acquisitions (22574)
Metabolic disorders (1437)
Multiple sclerosis (173)
NASH (23)
Neurodegenerative disease (366)
Neuropsychiatric disorders (105)
Neuroscience (3172)
Neurotech (1)
NextGen: Class of 2026 (7659)
Non-profit (5117)
Now hiring (68)
Obesity (701)
Opinion (339)
Ovarian cancer (170)
Pain (219)
Pancreatic cancer (240)
Parkinson's disease (302)
Partnered (36)
Patents (524)
Patient recruitment (517)
Peanut (61)
People (65573)
Pharmaceutical (134)
Pharmacy benefit managers (33)
Phase 1 (23435)
Phase 2 (33018)
Phase 3 (24896)
Pipeline (5516)
Policy (343)
Postmarket research (3242)
Preclinical (10287)
Press Release (72)
Prostate cancer (254)
Psychedelics (59)
Radiopharmaceuticals (307)
Rare diseases (951)
Real estate (7174)
Recruiting (81)
Regulatory (28368)
Reports (69)
Research institute (2730)
Resumes & cover letters (582)
Rett syndrome (28)
RNA editing (21)
RSV (87)
Schizophrenia (162)
Series A (263)
Series B (204)
Service/supplier (26)
Sickle cell disease (106)
Special edition (28)
Spinal muscular atrophy (177)
Sponsored (49)
Startups (4233)
State (2)
Stomach cancer (20)
Supply chain (113)
Tariffs (101)
The Weekly (122)
Vaccines (1173)
Venture capital (100)
Weight loss (482)
Women's health (94)
Worklife (22)
Date
Today (143)
Last 7 days (606)
Last 30 days (2368)
Last 365 days (32194)
2026 (3916)
2025 (32524)
2024 (37892)
2023 (42566)
2022 (53927)
2021 (58722)
2020 (57663)
2019 (51301)
2018 (39082)
2017 (36798)
2016 (37684)
2015 (43679)
2014 (38274)
2013 (34201)
2012 (36156)
2011 (36232)
2010 (35565)
Location
Africa (1206)
Alabama (92)
Alaska (7)
Arizona (323)
Arkansas (14)
Asia (50063)
Australia (8567)
California (11807)
Canada (3380)
China (1202)
Colorado (503)
Connecticut (513)
Delaware (354)
Europe (113278)
Florida (1746)
Georgia (380)
Hawaii (4)
Idaho (67)
Illinois (961)
India (73)
Indiana (556)
Iowa (24)
Japan (449)
Kansas (134)
Kentucky (43)
Louisiana (30)
Maine (83)
Maryland (1473)
Massachusetts (8667)
Michigan (359)
Minnesota (674)
Mississippi (6)
Missouri (143)
Montana (36)
Nebraska (29)
Nevada (128)
New Hampshire (85)
New Jersey (3176)
New Mexico (33)
New York (3117)
North Carolina (1635)
North Dakota (10)
Northern California (5688)
Ohio (360)
Oklahoma (23)
Oregon (53)
Pennsylvania (2353)
Puerto Rico (25)
Rhode Island (51)
South America (1574)
South Carolina (68)
South Dakota (1)
Southern California (4566)
Tennessee (179)
Texas (1847)
United States (42456)
Utah (353)
Vermont (1)
Virginia (297)
Washington D.C. (88)
Washington State (988)
West Virginia (4)
Wisconsin (132)
Wyoming (2)
839,715 Results for "genor biopharma co ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
vTv Therapeutics Amends License Agreement with Newsoara Biopharma Co. Ltd. for PDE4 inhibitor, HPP737
February 2, 2026
·
7 min read
Career Advice
The Top 12 Companies Hiring in Biopharma Now
Looking for a biopharma job? Check out the
BioSpace
list of 12 top companies hiring life sciences professionals like you.
February 5, 2026
·
1 min read
·
Angela Gabriel
Press Releases
Cumulus Neuroscience Enters Japanese Market to Advance Novel Cognitive Biomarkers with New Customer Shionogi & Co., Ltd.
February 10, 2026
·
4 min read
Press Releases
Quantum BioPharma Ltd. Announces Corporate Updates
October 30, 2025
·
11 min read
Press Releases
Kaida BioPharma Appoints Co-Founder Dr. Stella K. Vnook as Chairperson of the Board
January 23, 2026
·
4 min read
Press Releases
Cellyan Biotechnology Co., Ltd Receives Nasdaq Notice of Bid Price Deficiency
January 19, 2026
·
4 min read
Opinion
Biopharma Must Cope With The Fetal Bovine Serum Squeeze
The limited supply of this common reagent is set to drive drug prices higher, but there are ways for companies to lessen the impact.
February 17, 2026
·
5 min read
·
Tom Kutrubes
Press Releases
Amphastar Pharmaceuticals Announces Exclusive License Agreement with Nanjing Hanxin Pharmaceutical Technology Co., Ltd. for Fully Synthetic Corticotropin Compound
January 12, 2026
·
5 min read
JPM
JPM26: Biopharma Projected Positivity in San Francisco. Now It’s Time To Execute
With the biopharma industry performing better of late, analysts, executives and other industry watchers are “cautiously optimistic”—a term heard all over the streets of San Francisco at the J.P. Morgan Healthcare Conference earlier this month.
January 27, 2026
·
6 min read
·
Annalee Armstrong
Layoffs
Biopharmas Axed 47% More Employees Year Over Year
In 2025, made or projected biopharma workforce cuts affected about 42,700 employees, according to
BioSpace
tallies.
BioSpace
takes a deep dive into which companies and locations were impacted and speaks to experts about what to expect ahead—and why.
January 8, 2026
·
5 min read
·
Angela Gabriel
1 of 83,972
Next
